EUVIMEDSkopri EUVIMED
Crossref

The Development of Novel Antimalarial Drugs

Dr. Samuel Patel

American Journal Of Pharmacy And Pharmacology · 2023-06-30 · 4 (3) · 1-5

DOI: 10.71465/ajpp.2297 ↗

At a glance

Journal article in American Journal Of Pharmacy And Pharmacology, published online on 2023-06-30. Written by Dr. Samuel Patel.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Malaria remains one of the most devastating infectious diseases globally, causing millions of deaths annually. Despite advances in prevention and treatment, drug resistance continues to be a major challenge in malaria control. This article reviews the development of novel antimalarial drugs, focusing on new classes of drugs, their mechanisms of action, and their potential for overcoming drug resistance. We explore the latest research on artemisinin-based combination therapies, as well as innovative approaches such as the use of natural products, gene editing, and immune modulation. Additionally, the article highlights the challenges faced in the development of new drugs and the need for continued investment in research and development.

Cite

APA

Patel, D. S. (2023). The Development of Novel Antimalarial Drugs. American Journal Of Pharmacy And Pharmacology, 4(3), 1-5. https://doi.org/10.71465/ajpp.2297

Vancouver

Patel DS. The Development of Novel Antimalarial Drugs. American Journal Of Pharmacy And Pharmacology. 2023;4(3):1-5. doi:10.71465/ajpp.2297

BibTeX
@article{Patel2023,
  author = {Patel, Dr. Samuel},
  title = {The Development of Novel Antimalarial Drugs},
  journal = {American Journal Of Pharmacy And Pharmacology},
  year = {2023},
  volume = {4},
  number = {3},
  pages = {1--5},
  doi = {10.71465/ajpp.2297}
}
Start for free →